ORBIMED ADVISORS LLC 13D and 13G filings for Aerpio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-11-12 5:15 pm Purchase |
2020-11-10 | 13D | Aerpio Pharmaceuticals, Inc. ARPO |
ORBIMED ADVISORS LLC | 346,263 11.000% |
346,263 (New Position) |
Filing |